An analysis of FDA data found hundreds of postmarket studies running behind schedule, raising questions about the agency’s ability to ensure manufacturers follow through.

CONNECTA Therapeutics, a clinical-stage biotech company pioneering first-in-class neuroplasticity modulators to address unmet medical needs in central nervous system (CNS) disorders announced that it ...

The Iowa Board of Regents Wednesday provided initial approval for a slate of new programs and university initiatives, ...

OpenEvidence and Penn Medicine announced a global partnership on September 15, 2026, to bring AI-powered clinical decision ...

Dr. Shah, professor of clinical radiology and Director of Clinical Trials, is theAssociate Chair for Quality and Safety, effective August 1. This high-visibility role within the department and Health ...

The National Institutes of Health’s screening process for grants violates the First Amendment, more than a dozen researchers argue.

The National Institutes of Health (NIH) is awarding $21 million to launch a research program aimed at spurring the ...

Researchers at University of California San Diego School of Medicine have published the first study to define early-onset cirrhosis caused by ...

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer, announced new research ...

Faeth Therapeutics, Inc. (Nasdaq: FTH), a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways, today ...

MSU researchers lead a $4.6 million NIH-funded project using AI and computational models to improve medication safety and precision care for women.